- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Financially Fit Penny Stocks
U.S. Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
215
7 new
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
215 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ZYNE | US$1.30 | 4.0% | 96.1% | US$65.6m | US$1.26 | PB2.3x | E67.2% | n/a | ||
PBYI | US$3.00 | 24.0% | -30.9% | US$147.3m | US$4.33 | PE6.3x | E-45.4% | n/a | ||
CTXR | US$0.13 | -33.1% | -83.1% | US$25.8m | US$4.00 | PB0.3x | E53.0% | n/a | ||
KPRX | US$3.37 | 2.4% | -31.9% | US$10.1m | US$30.33 | PE1.8x | E-40.4% | n/a | ||
BFRI | US$0.87 | 18.5% | -72.8% | US$4.8m | US$11.50 | PS0.1x | E72.2% | n/a | ||
UNCY | US$0.53 | 15.2% | -12.4% | US$55.0m | US$5.50 | PB2x | E58.8% | n/a | ||
EVAX New | US$1.49 | 3.5% | -82.7% | US$8.3m | US$11.56 | PS2.5x | E69.9% | n/a | ||
PLX | US$1.69 | 20.7% | 18.2% | US$124.4m | US$14.00 | PS2.7x | E118.3% | n/a | ||
EVOK | US$4.33 | -5.5% | -71.1% | US$6.4m | US$18.00 | PS0.7x | E124.7% | n/a | ||
OBSE.F | US$0.0001 | 0% | -99.8% | US$11.7k | n/a | PE0.001x | n/a | n/a | ||
ACIU | US$3.38 | 6.0% | 10.5% | US$334.4m | US$10.15 | PS7.3x | E54.7% | n/a | ||
EPIX | US$1.83 | 6.4% | -68.1% | US$81.2m | US$9.50 | PB0.6x | E43.8% | n/a | ||
PRPH | US$0.77 | 2.5% | -82.9% | US$18.4m | US$18.50 | PS1.4x | E77.4% | 0% | ||
CABA | US$1.87 | -38.3% | -90.0% | US$91.4m | US$22.10 | PB0.5x | E-10.0% | n/a | ||
GNLX | US$2.55 | 8.1% | -77.0% | US$87.0m | US$18.40 | PS10870.1x | E12.0% | n/a | ||
HBIO | US$2.27 | 6.1% | -51.3% | US$99.0m | US$6.25 | PS1x | E82.2% | n/a | ||
XBIO | US$4.11 | 11.2% | 34.6% | US$6.3m | n/a | PS2.5x | E-34.4% | n/a | ||
PMCB | US$1.70 | 3.7% | -26.0% | US$13.1m | n/a | PE2.9x | n/a | n/a | ||
ALDX | US$4.85 | 15.2% | 91.7% | US$288.8m | US$10.00 | PB3.4x | E71.6% | n/a | ||
SGMT | US$4.76 | 0.6% | 16.1% | US$153.2m | US$29.17 | PB0.9x | E-33.5% | n/a | ||
GRCE | US$3.28 | 5.5% | 55.1% | US$33.3m | US$10.58 | PB0.6x | E49.6% | n/a | ||
LYEL | US$0.95 | -13.6% | -43.5% | US$265.3m | US$2.00 | PS4210.5x | E-15.2% | n/a | ||
CMRX | US$0.90 | 4.7% | -5.5% | US$80.9m | US$7.00 | PS509.1x | E36.1% | n/a | ||
MRKR | US$3.10 | 1.0% | 11.1% | US$27.7m | US$19.00 | PS5.1x | E-38.9% | n/a |